Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 040946/0037 | |
| Pages: | 7 |
| | Recorded: | 01/11/2017 | | |
Attorney Dkt #: | Q230739 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
|
Issue Dt:
|
06/05/2018
|
Application #:
|
15325521
|
Filing Dt:
|
01/11/2017
|
Publication #:
|
|
Pub Dt:
|
06/01/2017
| | | | |
Title:
|
NOVEL CRYSTALLINE FORM OF 5-CHLORO-N-({(5S)-2-OXO-3-[4-(5,6-DIHYDRO-4H-[1,2,4]TRIAZIN-1-YL)PHENYL]-1,3-OXAZOLIDIN-5-YL}METHYL)THIOPHENE-2-CARBOXAMIDE METHANESULFONATE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
|
|
Assignees
|
|
|
107, IHYEON-RO 30BEON-GIL, GIHEUNG-GU |
YONGIN-SI, GYEONGGI-DO, KOREA, REPUBLIC OF 446-770 |
|
|
|
8-26, MUNPYEONGSEO-RO, DAEDEOK-GU |
DAEJEON, KOREA, REPUBLIC OF 306-220 |
|
Correspondence name and address
|
|
SUGHRUE MION, PLLC
|
|
2100 PENNSYLVANIA AVENUE NW
|
|
WASHINGTON, DC 20037
|
Search Results as of:
04/27/2024 11:45 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|